肌醇/二千-肌醇联合疗法治疗多囊卵巢综合征的最新进展。

IF 2 4区医学 Q3 ENDOCRINOLOGY & METABOLISM

Gynecological Endocrinology Pub Date : 2024-12-01 Epub Date: 2024-01-18 DOI:10.1080/09513590.2023.2301554

Iñaki Lete, Ainara Martínez, Irene Lasaga, Eva Centurión, Amaia Vesga

{"title":"肌醇/二千-肌醇联合疗法治疗多囊卵巢综合征的最新进展。","authors":"Iñaki Lete, Ainara Martínez, Irene Lasaga, Eva Centurión, Amaia Vesga","doi":"10.1080/09513590.2023.2301554","DOIUrl":null,"url":null,"abstract":"In this article, we present a narrative review on the use of inositol in the treatment of polycystic ovary syndrome (PCOS). Of the different inositols that exist, only myo-inositol (MYO) and D-chiro inositol (DCI) have been studied in the treatment of PCOS. The results of the studies show that there is insufficient or controversial evidence to recommend the use of DCI alone, while MYO alone shows positive results and, above all, the MYO/DCI combination is effective when used at a ratio of at least 40:1, but there is enough rationale to further study ratios such as 66:1 to 100:1 as other possible effective combinations.","PeriodicalId":12865,"journal":{"name":"Gynecological Endocrinology","volume":"40 1","pages":"2301554"},"PeriodicalIF":2.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome.\",\"authors\":\"Iñaki Lete, Ainara Martínez, Irene Lasaga, Eva Centurión, Amaia Vesga\",\"doi\":\"10.1080/09513590.2023.2301554\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In this article, we present a narrative review on the use of inositol in the treatment of polycystic ovary syndrome (PCOS). Of the different inositols that exist, only myo-inositol (MYO) and D-chiro inositol (DCI) have been studied in the treatment of PCOS. The results of the studies show that there is insufficient or controversial evidence to recommend the use of DCI alone, while MYO alone shows positive results and, above all, the MYO/DCI combination is effective when used at a ratio of at least 40:1, but there is enough rationale to further study ratios such as 66:1 to 100:1 as other possible effective combinations.\",\"PeriodicalId\":12865,\"journal\":{\"name\":\"Gynecological Endocrinology\",\"volume\":\"40 1\",\"pages\":\"2301554\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gynecological Endocrinology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/09513590.2023.2301554\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/18 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecological Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09513590.2023.2301554","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/18 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

摘要

在本文中，我们对肌醇在治疗多囊卵巢综合症（PCOS）中的应用进行了叙述性综述。在现有的各种肌醇中，只有肌醇（MYO）和D-肌醇（DCI）被研究用于治疗多囊卵巢综合症。研究结果表明，建议单独使用 DCI 的证据不足或存在争议，而单独使用 MYO 则显示出积极的效果，最重要的是，MYO/DCI 组合在以至少 40:1 的比例使用时是有效的，但有足够的理由进一步研究 66:1 至 100:1 等其他可能的有效组合比例。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome.

In this article, we present a narrative review on the use of inositol in the treatment of polycystic ovary syndrome (PCOS). Of the different inositols that exist, only myo-inositol (MYO) and D-chiro inositol (DCI) have been studied in the treatment of PCOS. The results of the studies show that there is insufficient or controversial evidence to recommend the use of DCI alone, while MYO alone shows positive results and, above all, the MYO/DCI combination is effective when used at a ratio of at least 40:1, but there is enough rationale to further study ratios such as 66:1 to 100:1 as other possible effective combinations.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Gynecological Endocrinology 医学-妇产科学

CiteScore

4.40

自引率

5.00%

发文量

137

审稿时长

3-6 weeks

期刊介绍： Gynecological Endocrinology , the official journal of the International Society of Gynecological Endocrinology, covers all the experimental, clinical and therapeutic aspects of this ever more important discipline. It includes, amongst others, papers relating to the control and function of the different endocrine glands in females, the effects of reproductive events on the endocrine system, and the consequences of endocrine disorders on reproduction